Brett P. Monia's holdings in Ionis Pharmaceuticals have shown significant growth, particularly over the last couple of years. He notably increased his stock sales in January 2023, peaking with trades valued at $4.20 million. The highest recorded sales were around...

Brett P. Monia's holdings in Ionis Pharmaceuticals have shown significant growth, particularly over the last couple of years. He notably increased his stock sales in January 2023, peaking with trades valued at $4.20 million. The highest recorded sales were around $8.45 million in June 2024, demonstrating his increasing confidence in the company's direction and performance. His wealth through these holdings indicates a strong belief in the company's future and growth potential. Monia has strategically navigated his stock options over the years, underscoring his commitment to Ionis’s success and aligning his financial interests with those of its shareholders.